Education
About Us
Working with TipRanks
Follow Us
Proteomics International Laboratories Ltd. (AU:PIQ)
ASX:PIQ
PIQ Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.46 - AU$1.30
Previous CloseN/A
Volume90.30K
Average Volume (3M)122.33K
Market Cap
AU$65.50M
Enterprise ValueAU$108.70M
Total Cash (Recent Filing)AU$2.93M
Total Debt (Recent Filing)AU$84.77K
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding131,002,720
10 Day Avg. Volume85,248
30 Day Avg. Volume122,326
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)57.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.50Price Target Upside0.00%
Rating ConsensusModerate Sell
Number of Analyst Covering1
---
Proteomics International Laboratories Ltd. News
PremiumCompany Announcements
Proteomics International Secures Australian Patent for OxiDx Test
PremiumCompany Announcements
Proteomics International to Unveil New Diagnostic Tests at Biotech Event
PremiumCompany Announcements
PromarkerD Test Revolutionizes Diabetic Kidney Disease Prediction
PremiumCompany Announcements
Proteomics International Reports Revenue Growth Amid Increased Losses
PremiumCompany Announcements
Proteomics International Appoints New Company Secretary---
Options Prices
Currently, No data available
---
Ownership Overview
12.53%
Insiders
―
Mutual Funds
― Other Institutional Investors
87.47% Public Companies and
Individual Investors
PIQ FAQ
What was Proteomics International Laboratories Ltd.’s price range in the past 12 months?
Proteomics International Laboratories Ltd. lowest share price was AU$0.46 and its highest was AU$1.29 in the past 12 months.
What is Proteomics International Laboratories Ltd.’s market cap?
Proteomics International Laboratories Ltd.’s market cap is AU$65.50M.
When is Proteomics International Laboratories Ltd.’s upcoming earnings report date?
Proteomics International Laboratories Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 153 days.
How were Proteomics International Laboratories Ltd.’s earnings last quarter?
Proteomics International Laboratories Ltd. released its earnings results on Feb 25, 2025. The company reported -AU$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.03.
Is Proteomics International Laboratories Ltd. overvalued?
According to Wall Street analysts Proteomics International Laboratories Ltd.’s price is currently same.
Does Proteomics International Laboratories Ltd. pay dividends?
Proteomics International Laboratories Ltd. does not currently pay dividends.
What is Proteomics International Laboratories Ltd.’s EPS estimate?
Proteomics International Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteomics International Laboratories Ltd. have?
Proteomics International Laboratories Ltd. has 131,002,720 shares outstanding.
What happened to Proteomics International Laboratories Ltd.’s price movement after its last earnings report?
Proteomics International Laboratories Ltd. reported an EPS of -AU$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of Proteomics International Laboratories Ltd.?
Currently, no hedge funds are holding shares in AU:PIQ
---
Proteomics International Laboratories Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
AU$0.50 (0.00% )
AU$0.50 (0.00% )
Blogger Sentiment
Bullish
AU:PIQ Sentiment 95%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.52%
12-Months-Change
Fundamentals
Return on Equity
-131.55%
Trailing 12-Months
Asset Growth
1.07%
Trailing 12-Months
Company Description
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute and the Janssen Research & Development for the research of diabetic kidney disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma. The company was founded in 2001 and is based in Perth, Australia.
---
PIQ Stock 12 Month Forecast
Average Price Target
AU$0.50
▲(0.00% Upside)
Technical Analysis
Opthea Limited
―
Neuren Pharmaceuticals Limited
―
Telix Pharmaceuticals Ltd.
―
Race Oncology Ltd.
―
Cyclopharm Limited
―
Best Analysts Covering PIQ
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+24.30%
reiterated a sell rating 2 months ago
Copying Iain Wilkie's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +24.30% per trade.
---